From Casetext: Smarter Legal Research

Dzuryachko v. Teva Pharm. U.S.

United States District Court, E.D. Pennsylvania
Mar 21, 2022
Civil Action 20-5217 (E.D. Pa. Mar. 21, 2022)

Opinion

Civil Action 20-5217

03-21-2022

MATTHEW DZURYACHKO, Plaintiff, v. TEVA PHARMACEUTICALS USA, INC., Defendant.


ORDER

CYNTHIA M. RUFE, J.

AND NOW, this 21st day of March 2022, upon consideration of Defendant's Motion for Summary Judgment [Doc. No. 20] and the related briefing, and for the reasons stated in the Memorandum Opinion, it is hereby ORDERED that the Motion is GRANTED in part and DENIED in part. Summary judgment is GRANTED as to Plaintiff's USERRA and PMAA claims and DENIED as to all other claims.

It is further ORDERED that Plaintiff's Motion to Strike Defendant's Expert Report and Witness [Doc. No. 17] and Defendant's Motion to Strike Plaintiff's Expert Report and Witness [Doc. No. 21] are DISMISSED without prejudice with leave to refile at such time that the case is scheduled for trial. The parties, through counsel, shall submit a joint report in writing on or before April 8, 2022 as to whether they wish to resume settlement discussions before Judge Wells or pursue another form of alternative dispute resolution. The joint report should be submitted by email to Chambersof JudgeCynthiaMRufe@paed.uscourts.gov and not filed of record.

It is so ORDERED.


Summaries of

Dzuryachko v. Teva Pharm. U.S.

United States District Court, E.D. Pennsylvania
Mar 21, 2022
Civil Action 20-5217 (E.D. Pa. Mar. 21, 2022)
Case details for

Dzuryachko v. Teva Pharm. U.S.

Case Details

Full title:MATTHEW DZURYACHKO, Plaintiff, v. TEVA PHARMACEUTICALS USA, INC.…

Court:United States District Court, E.D. Pennsylvania

Date published: Mar 21, 2022

Citations

Civil Action 20-5217 (E.D. Pa. Mar. 21, 2022)